Literature DB >> 24555183

Presence of symptom clusters in surgically treated patients with esophageal cancer: implications for survival.

Anna Wikman, Asif Johar, Pernilla Lagergren.   

Abstract

BACKGROUND: It is not known whether symptoms cluster together after esophageal cancer surgery or whether such symptom clusters are associated with survival in patients with esophageal cancer who are treated surgically.
METHODS: Data from a prospective Swedish nationwide cohort study of surgically treated patients with esophageal cancer recruited between 2001 and 2005 were used. General and esophageal cancer-specific symptoms were assessed using the European Organization for Research and Treatment of Cancer QLQ-C30 quality of life questionnaire and the QLQ-OES18 module at 6 months after surgery. Associations between symptom clusters and survival were analyzed using Cox proportional hazards models, providing hazards ratios with 95% confidence intervals, adjusted for other known prognostic factors.
RESULTS: Among 402 patients reporting symptoms 6 months after surgery, 3 symptom clusters were identified. The first symptom cluster (“fatigue/pain”) was characterized by symptoms of pain, fatigue, insomnia, and dyspnea and was present in 30% of patients. The second symptom cluster (“reflux/cough”) was characterized by symptoms of dry mouth, problems with taste, coughing, and reflux and was present in 27% of patients. The third symptom cluster (“eating difficulties”) was characterized by appetite loss, dysphagia, eating difficulties, and nausea/vomiting and was present in 28% of patients. The presence of the reflux/cough and eating difficulties symptom clusters was associated with a statistically significantly increased risk of mortality (adjusted hazards ratio, 1.43 [95% confidence interval, 1.08-1.89] and adjusted HR, 1.41 [95% confidence interval, 1.06-1.87], respectively).
CONCLUSIONS: Symptoms experienced by surgically treated patients with esophageal cancer appear to cluster together, and the presence of these symptom clusters appears to have strong prognostic value.

Entities:  

Mesh:

Year:  2014        PMID: 24555183     DOI: 10.1002/cncr.28308

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers.

Authors:  Andrea L Cheville; Steven R Alberts; Teresa A Rummans; Jeffrey R Basford; Maria I Lapid; Jeff A Sloan; Daniel V Satele; Matthew M Clark
Journal:  J Pain Symptom Manage       Date:  2015-05-12       Impact factor: 3.612

2.  Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy.

Authors:  Kotaro Sugawara; Shuntaro Yoshimura; Koichi Yagi; Masato Nishida; Susumu Aikou; Yukinori Yamagata; Kazuhiko Mori; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

3.  Stability of Symptom Clusters in Patients With Gastrointestinal Cancers Receiving Chemotherapy.

Authors:  Claire J Han; Kerryn Reding; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn Hammer; Kord M Kober; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-08-09       Impact factor: 3.612

4.  Symptom Clusters in Patients With Gastrointestinal Cancers Using Different Dimensions of the Symptom Experience.

Authors:  Claire J Han; Kerryn Reding; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn Hammer; Fay Wright; Frances Cartwright; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-05-09       Impact factor: 3.612

5.  Profiling patient-reported symptom recovery from oesophagectomy for patients with oesophageal squamous cell carcinoma: a real-world longitudinal study.

Authors:  Xi Luo; Qin Xie; Qiuling Shi; Yan Miao; Qingsong Yu; Hongfan Yu; Hong Yin; Xuefeng Leng; Yongtao Han; Hong Zhou
Journal:  Support Care Cancer       Date:  2021-11-24       Impact factor: 3.603

6.  The potential for autonomic neuromodulation to reduce perioperative complications and pain: a systematic review and meta-analysis.

Authors:  Amour B U Patel; Valentin Weber; Alexander V Gourine; Gareth L Ackland
Journal:  Br J Anaesth       Date:  2021-11-18       Impact factor: 9.166

Review 7.  Health-related quality of life after esophagectomy in patients with esophageal cancer.

Authors:  Yasushi Toh; Masaru Morita; Manabu Yamamoto; Yuichiro Nakashima; Masahiko Sugiyama; Hideo Uehara; Yoshiaki Fujimoto; Yuki Shin; Keiichi Shiokawa; Emi Ohnishi; Tomonari Shimagaki; Yohei Mano; Keishi Sugimachi
Journal:  Esophagus       Date:  2021-09-01       Impact factor: 4.230

8.  Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.

Authors:  Dietmar Tamandl; Matthias Paireder; Reza Asari; Pascal A Baltzer; Sebastian F Schoppmann; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

9.  A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment.

Authors:  Maria Browall; Yvonne Brandberg; Salmir Nasic; Per Rydberg; Jonas Bergh; Andreas Rydén; Hanjing Xie; Irene Eriksson; Yvonne Wengström
Journal:  Support Care Cancer       Date:  2016-12-15       Impact factor: 3.603

10.  Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study.

Authors:  Tommi Järvinen; Ilkka Ilonen; Juha Kauppi; Kirsi Volmonen; Jarmo Salo; Jari Räsänen
Journal:  Thorac Cancer       Date:  2018-08-29       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.